BioSpace News Archive

Puration, Inc. (USOTC: PURA) today confirmed a scheduled update with more details on the company’s recently announced 2020 expansion plan to be released next week on Tuesday, December 17, 2019. PURA’s expansion is intended to substantially increase PURA’s 2020 prospects beyond its current $8 million revenue target.

The U.S. Food and Drug Administration today authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an interoperable automated glycemic controller device that automatically adjusts insulin delivery to a person with diabetes by connecting to an alternate controller-enabled insulin pump (ACE pump) and integrated continuous glucose monitor (iCGM)

Arthroscopy, also known as arthroscopic or keyhole surgery, is a minimally invasive surgical procedure on a joint. An arthroscope, a device with a camera is inserted into the joint through a small incision in arthroscopy.

Capital Health Medical Group is pleased to announce the addition of Women’s Specialists of Bucks County, a comprehensive OB/GYN practice, to its growing network of specialty care providers.

Moog Inc. (NYSE: MOG.A and MOG.B) announced today that a notice of redemption is being issued to the holders of the Company’s 5.25% senior notes due in 2022 (the “Notes”), to redeem and retire all of the outstanding Notes.

The U.S. Food and Drug Administration today cleared for marketing in the U.S. the first fully disposable duodenoscope.

ITF Pharma, a U.S.-based specialty pharmaceutical company and subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label for TIGLUTIK®

Takeda Pharmaceuticals U.S.A. (TSE: 4502) (NYSE:TAK) (“Takeda”) and MiTest Health LLC (“MiTest”), a pioneering health technology company, today announced an exclusive partnership to optimize MiTest’s personalized risk and outcome prediction tool for widespread use in patients with Crohn’s disease (CD).

Technavio has been monitoring the neurodiagnostic and monitoring devices market in the US since 2016 and the market is poised to grow by USD 443.81 million during 2020-2024 at a CAGR of over 7% during the forecast period

The California Speech Language Hearing Association (CSHA) is thrilled to announce its implementation of comprehensive brand and communications strategies designed to build on CSHA’s 53-year record of serving its members and the people who need them, and to tell the stories of their life-changing work.